Pulse Biosciences (PLSE) | Stock Overview & Key Data
Pulse Biosciences Performance Comparison
Stock Range
Today's Range
Low: $15.81
High: $16.20
on August 21, 2025
52 Week Range
Low: $13.77
High: $25.00
on April 4, 2025
on February 5, 2025
All-Time High: $45.82 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.1B
EPS
-1.08
P/E Ratio (TTM)
-17.36
Forward P/E
-17.62
P/B Ratio
10.21
PEG Ratio
-0.43
Div. Yield
N/A
ROE
-103.50%
Beta
1.601
Debt to Equity
7.89
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
0.00%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-56.19%
Return on Equity (TTM)
-103.50%
EBITDA
$-71.1M
Net Income (TTM)
$-68.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
N/A
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences PLSE | 1.07B Small-cap | -7.57% | 6.88% | -7.51% | -17.82% | -10.06% | -25.51% | 1,130.77% | 63.10% |
| Intuitive Surgical ISRG | 171.78B Large-cap | -1.51% | -8.96% | -14.11% | -20.60% | -10.33% | -3.43% | 122.60% | 93.89% |
| Becton, Dickinson BDX | 56.27B Large-cap | 0.84% | 12.15% | 13.57% | -13.54% | -13.18% | -16.82% | -22.50% | -16.99% |
| AtriCure ATRC | 1.76B Small-cap | 0.90% | 22.20% | 7.43% | -6.93% | 17.53% | 40.45% | -24.04% | -15.97% |
| Azenta AZTA | 1.41B Small-cap | -2.45% | -4.73% | 8.59% | -33.32% | -40.37% | -39.40% | -46.75% | -42.97% |
| Staar Surgical STAA | 1.39B Small-cap | -2.80% | 56.36% | 50.51% | 64.61% | 15.23% | -16.53% | -71.80% | -39.17% |
Ownership & Short Interest
Insider Ownership
74.00%
Institutional Ownership
9.07%
Shares Short
2M
Short Ratio
15.22
Short % of Shares Outstanding
15.82%
Average 10-Day Volume
198K
Average 90-Day Volume
162K
Pulse Biosciences Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Pulse Biosciences would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PLSE's 52-week high and low?
- In the last 52 weeks, Pulse Biosciences reached a high of $25.00 (on February 5, 2025) and a low of $13.77 (on April 4, 2025).
- What is the market cap and P/E ratio for PLSE?
- Curious about Pulse Biosciences's size and valuation? Its market capitalization stands at 1.07B. When it comes to valuation, the P/E ratio (trailing twelve months) is -17.36, and the forward P/E (looking ahead) is -17.62.
- Does PLSE pay dividends? If so, what's the yield?
- As for dividends, Pulse Biosciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Pulse Biosciences's main competitors or similar companies to consider before investing?
When looking at Pulse Biosciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG171.78B Healthcare Medical Instruments & Supplies -3.43% 122.60% Becton, Dickinson
BDX56.27B Healthcare Medical Instruments & Supplies -16.82% -22.50% AtriCure
ATRC1.76B Healthcare Medical Instruments & Supplies 40.45% -24.04% Azenta
AZTA1.41B Healthcare Medical Instruments & Supplies -39.40% -46.75% Staar Surgical
STAA1.39B Healthcare Medical Instruments & Supplies -16.53% -71.80% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Pulse Biosciences Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Pulse Biosciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -103.50%, the Debt to Equity ratio from the most recent quarter is 7.89, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for PLSE?
- Looking at Pulse Biosciences's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of PLSE stock is held by insiders and institutions?
- Wondering who owns Pulse Biosciences stock? Company insiders (like executives and directors) hold about 74.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 9.07%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.